DST Gene Epidermolysis Bullosa Simplex Autosomal Recessive Type 2 NGS Genetic DNA Test
Comprehensive Genetic Analysis for Severe Skin Fragility Disorders
The DST Gene Epidermolysis Bullosa Simplex Autosomal Recessive Type 2 NGS Genetic DNA Test represents a breakthrough in molecular diagnostics for rare inherited skin disorders. This advanced genetic test utilizes next-generation sequencing technology to identify specific mutations in the DST gene that cause epidermolysis bullosa simplex, a condition characterized by extreme skin fragility and recurrent blistering.
What This Test Measures and Detects
This comprehensive genetic analysis specifically targets the DST gene, which encodes dystonin, a crucial protein involved in maintaining skin integrity and cellular structure. The test detects:
- Point mutations and single nucleotide variants in the DST gene
- Small insertions and deletions affecting gene function
- Autosomal recessive inheritance patterns
- Specific genetic variants associated with Type 2 epidermolysis bullosa simplex
- Mutation hotspots and known pathogenic variants
Who Should Consider This Genetic Test
This test is recommended for individuals experiencing:
- Unexplained skin fragility and easy blistering
- Recurrent skin erosions with minimal trauma
- Family history of epidermolysis bullosa or similar skin disorders
- Delayed wound healing and chronic skin complications
- Nail dystrophy and mucosal membrane involvement
- Previous inconclusive dermatological evaluations
Clinical Benefits of Genetic Testing
Undergoing the DST gene test provides numerous clinical advantages:
- Accurate Diagnosis: Confirms or rules out epidermolysis bullosa simplex with precision
- Personalized Treatment: Enables targeted management strategies based on genetic findings
- Family Planning: Provides crucial information for genetic counseling and reproductive decisions
- Prognostic Insights: Helps predict disease progression and potential complications
- Therapeutic Guidance: Informs appropriate wound care and skin protection protocols
Understanding Your Test Results
Your genetic test results will be thoroughly explained by our certified genetic counselors:
- Positive Result: Indicates the presence of pathogenic DST gene mutations, confirming diagnosis
- Negative Result: Suggests absence of tested mutations, though other genetic causes may exist
- Variant of Uncertain Significance: Requires additional clinical correlation and family studies
- Carrier Status: Identifies individuals who carry one copy of the mutated gene
Test Pricing and Details
| Test Component | Details |
|---|---|
| Test Name | DST Gene Epidermolysis Bullosa Simplex Autosomal Recessive Type 2 NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
| Testing Method | Next-Generation Sequencing (NGS) Technology |
Nationwide Accessibility
We have diagnostic centers conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our nationwide network ensures accessible genetic testing services for patients throughout the country.
Take the Next Step Toward Genetic Clarity
If you or your loved ones are experiencing symptoms of skin fragility or have concerns about inherited skin conditions, our DST gene test provides the answers you need. Our team of genetic specialists, neurologists, and dermatologists work together to deliver comprehensive care and support throughout your testing journey.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your DST Gene Epidermolysis Bullosa Simplex Autosomal Recessive Type 2 NGS Genetic DNA Test. Take control of your genetic health with precise, reliable testing from America’s leading genetics laboratory.
